We need user-led research more now than ever before…

Slides:



Advertisements
Similar presentations
4 th Meeting of the EC International Dialogue on Bioethics Copenhagen, June 19 th, 2012 Large research and medical databases in clinical and research multi-centred.
Advertisements

Independence, Well-being and Choice Our Vision for the Future of Social Care for Adults in England.
NIHR Delivering Better Health Through Training Researchers 19 September 2011 Dr David Cox Deputy Director – Research Faculty.
NIHR Delivering Better Health 20 November 2012, Leeds Dr David Cox Deputy Director – Research Finance & Programmes.
Service user participation in clinical trials Partnership or Co-option? Dr. Jan Wallcraft Operational Manager of SURGE (Service User Research Group for.
Towards a New R&D Strategy A blueprint for R&D in Health and Social Care Noreen Caine Deputy Director of R&D, DH NHS R&D Forum Annual Conference May 2005.
E.g Act as a positive role model for innovation Question the status quo Keep the focus of contribution on delivering and improving.
A Proposal Dr Susan Hamer
West Midlands Academic Health Science Network Mental Health Clinical Priority Event October 10 th, 2013 Peter Lewis Medical Director, Birmingham and Solihull.
Increasing staff engagement across children’s services Di Smith Director of Children’s Services.
NSUN’s vision is to bring mental health service users and survivors together to communicate, feel supported and have the power and the platform from which.
Liberating the NHS HealthWatch DH GATEWAY REF
Vanessa Pinfold and Terry Hammond Developing a carer strategy for the UK Mental Health Research Network.
The Voice of Carers Developing carer organisations across Europe Sebastian Fischer VOCAL - Voice of Carers Across Lothian Coalition of Carers in Scotland.
“Best Research for Best Health” Andrew Riley Managing Director.
DFID review of impact of research on development – an MRC perspective
Learning from Experience: involving service users in research Alison Faulkner Survivor researcher.
The Key Role of Charities in Supporting Brain Research Marie Downes, MRCG Development Executive Brain Research in Ireland: Delivering on the Potential.
CUHP Cambridge University Health Partners (CUHP) unites a world-leading University and three high- performing NHS Foundation Trusts centred on the Cambridge.
Janet Darbyshire (25 June 07) UK Clinical Research Network (UKCRN) Identifying research priorities in the UK Clinical Research Network.
Wellcome Trust/Australia/New Zealand International Collaborative Research Grants  Up to £12 million funding for Large grants to foster collaborative research.
North West Coast Patient Safety Collaborative Presented by: Aly Hulme Associate Director.
Health Stakeholder Consultation Event Frances Spillane, Assistant Secretary General Department of Health 11 March 2015.
Welcome to The Expert Community Forum 19 November 2007.
U n i t 6 Multisectoral collaboration. © WHO, │ By the end of this unit, the trainee should be able to: explain why there is a need for multisectoral.
LIMITLESS POTENTIAL | LIMITLESS OPPORTUNITIES | LIMITLESS IMPACT Copyright University of Reading IMPACT AND THE SCIENCES Anthony Atkin (Research Impact.
Coming together to secure an equal future for people with disabilities Martin Naughton | Director of Áiseanna Tacaíochta.
Better Care – Stronger Communities Grants Programme July 2014.
Strategies of CBR Forum
The Chief Scientist Office. Developments/Restructuring Of Research Funding In Scotland Overview of NHS Infrastructure funding ( ) What we have.
National Collaborative Programme for Integrated Care & Support Keith Holden NHS England 25 September 2013.
What is PPI in research? Research which is done with or by patients and the public, rather than to, for or about them Involvement in research refers to.
AHSN Stakeholder Event Centre for Life, Newcastle Tuesday 23 rd June 2015 Patient Safety Collaboratives: the North East approach Tony Roberts, Interim.
Notions of involvement in North East research networks Dr Tina Cook & Dr Anna Jones, School of Health, Community and Education Studies, Northumbria University.
Genuine user involvement: what does it look like? Alison Faulkner Mental health researcher & service user.
Taking forward the Next Stage Review Clinical leadership and networks in the North.
Improving Outcomes through Integrated Care Dr Anne Hendry National Clinical Lead for Integrated Care Joint Improvement Team.
6 Key Priorities A “scorecard” for each of the 5 above priorities with end of 2009 deliverables – with a space beside each for a check mark (i.e. complete)
VCFP Review Report from the VCFP Steering Group. Why Review VCFP The external environment that we work in is significantly changing; there is a shift.
Commissioning High Quality Stroke Services
From Vision to Reality: Transitioning to Community- based Approaches …our journey so far 4 th May 2012.
“What’s in it for us?” NICE Guideline: Safe and Effective use of Medicines (Medicines Optimisation) Erin Whittingham Public Involvement Adviser Public.
Creating Citizen Leaders Preparing for Change National Citizen Leadership Programme Scotland.
Dorset Clinical Commissioning Group Dr Paul French.
Nottinghamshire Health & Wellbeing Board Peer Challenge Cathy Quinn Associate Director of Public Health.
Doing the Right Thing Unlocking the voluntary and community sector’s potential for making change happen in health and care.
Durham and Teesside Patient Safety Conference Teesside University Tuesday 31 st March 2015 Patient Safety Collaboratives: the North East approach Tony.
Devolution in the North East Opportunities for the VCSE Jane Hartley Chief Executive.
HPTN Ethics Guidance for Research: Community Obligations Africa Regional Working Group Meeting, May 19-23, 2003 Lusaka, Zambia.
Educational Solutions for Workforce Development EDUCATION & DEVELOPMENT FRAMEWORK FOR SENIOR AHPs SUSAN SHANDLEY EDUCATIONAL PROJECTS MANAGER, AHP CAREERS.
Community Pharmacy in 2016 and beyond: A summary of the Pharmacy Voice response Elizabeth Wade Director of Policy, Pharmacy Voice April 2016 Slide 1 of.
HEALTH AND CARE STANDARDS APRIL Background Ministerial commitment 2013 – Safe Care Compassionate Care Review “Doing Well Doing Better” Standards.
R&D Report to SL&M Board 17 September 2002 Graham Thornicroft Director of Research & Development Gill Dale Research & Development Manager.
Science & Technology for National Progress in African Region: Highlights of Regional Strategy and Action Professor Gabriel B. Ogunmola, FAS President,
Sanofi Train the Trainer Programme. Course objectives Understand what advocacy is Understand the roles of decision makers and how to influence them Understand.
Welcome Lynne Goodacre.  Over view of next 2 days  Overview of internship  Group coaching  Clarity re what they are required to produce by the end.
Patient Engagement throughout the Biopharmaceutical Lifecycle: Tips for Effective Patient Advocate/Industry Collaboration to Improve Patient Access and.
The Transformation of Social Care Janet Walden 13th November 2008.
Research and Development Dr Julie Hankin Medical Director.
BC SUPPORT Unit: Overview and update
Health Education England Workforce Strategy - Key Points
Research for all Sharing good practice in research management
Health Education England Workforce Strategy - Key Points
Kaisa Immonen EPF Director of Policy
Department of Applied Social Sciences
Simon Large – Chief Executive
Arthritis and Musculoskeletal Alliance
By: Andi Indahwaty Sidin A Critical Review of The Role of Clinical Governance in Health Care and its Potential Application in Indonesia.
STRATEGIC PLAN.
Stirling Bryan, PhD Scientific Director, BC SUPPORT Unit
Presentation transcript:

We need user-led research more now than ever before… Alison Faulkner Independent Service User Researcher & Trainer

We need user-led research more now than ever before… A few caveats… Research agenda of service users/survivors Changes taking place in the research world The role of the mental health charities What is the way forward for user/survivor research?

1. A few caveats… This is my own perspective Intended as a think-piece Based on my experience of the mental health research world Quite a lot of questions

A continuum of ‘involvement’ Consultation Collaboration Control Researcher-led User-led Joint Let us first remind ourselves of the involvement continuum – from consultation with the public/with service users on the left, through collaboration to user/public control on the right. Collaboration is what we are told we are doing when we become involved in research projects essentially designed or conceived of by clinical academic researchers. Control is not something that is common for service users, although it does happen and is happening. Consultation is all too common, in that it can be tokenistic and without any accountability.

Arnstein’s ladder of participation Citizen control Delegated power Partnerships Placation or tokenism Consultation Information Community development Arnstein, 1971. A ladder of citizen participation. Journal of the American Institute of Planners 69, 216-224. Community engagement

2. What is the service user/survivor research agenda? Research priorities Active participation in the process Asking different questions / getting different answers Methodology? Theoretical underpinnings Ethical practice Participation in the process Feedback to participants Change These priorities are based on a number of consultations I know about or have been involved with, the wide range of work I have been involved in and on research I conducted myself for the report ‘The Ethics of Survivor Research’. SLAM / SURE consultations The strategic review of mental health NHS R&D Leeds University seminars

2b The NHS R & D Strategic Review of Mental Health: priorities identified by service user panel support for full involvement of service users in the research process race equality user-defined outcomes holistic research approach research reviews to be more inclusive: to include ‘grey literature’ social approaches to mental health – moving beyond and outside of the medical model researching positive risk management self-management (as against ‘self-help interventions’ which do not redress the balance of power) evaluation of user-controlled services research into models of user involvement

3. Changes taking place in the research world ‘Best research for best health’: the new R&D strategy for England NIHR UKCRC, UKCRN The Research Networks Working with industry The Cooksey Review Review of RAE I am unable to speak with great authority on all of these developments, so have confined myself to the first few.

3a Best Research for Best Health: A new national health research strategy Our vision is to improve the health and wealth of the nation through research. We aim to create a health research system in which the NHS supports outstanding individuals, working in world-class facilities, conducting leading-edge research, focused on the needs of patients and the public.

3a. Best Research for Best Health: A new national health research strategy Objectives Expand and build a world-class NHS research infrastructure focused on delivering benefits to patients and the public Contribute to international excellence in experimental and translational medicine and innovation in healthcare Build on our reputation as a leading country for publicly funded research Become a leading country for conducting clinical research in partnership with and for industry Develop legislation and guidelines that create a vibrant and efficient research environment Respect ethical principles for health research. The main changes proposed by the strategy are: To alter the funding arrangements that have developed historically within the NHS where a large proportion of monies have ended up funding service provision To promote research amongst all clinical professions as a real alternative, creating incentives and a (virtual) National Institute for Health Research; To streamline some of the bureaucracy that has developed around getting research off the ground To promote relations with industry, ensuring that industry can make better use of NHS research facilities and NHS services and patients. NB the consultation stage did not mention user/public involvement at all, other than as participants in clinical trials. It was persuaded to do so in the final draft by the extent and nature, presumably, of responses to the consultation draft. With this clear commitment to public involvement in research, it is concerning that there is so little focus on the importance of public involvement and how this can assist in taking forward the aims and objectives of the research strategy. The emphasis is on the involvement of patients as participants in trials, rather than as partners with researchers in the design and planning of research. If the strategy is to achieve its’ aims, it is vital that service users and carers are actively involved in the research process. The strategy needs to provide a clear and strong lead on public involvement, to encourage researchers and research funders to recognise the importance of such involvement. if active public involvement in research were embedded into the mainstream of research practice it would contribute towards improving levels of public confidence and understanding of research as well as to the quality, relevance and acceptability of research. Research that is more relevant, appropriate and acceptable to participants is likely to encourage greater participation in research. Without greater public involvement, it will be difficult for the Department of Health to fully deliver in providing research for the benefit of patients and the wider public. Another telling piece of information includes the job descriptions for patient and public involvement reps throughout the research network, part of whose remit is to encourage patient involvement in clinical trials.

3b The UKCRC “A partnership working to establish the UK as a world leader in clinical research, by harnessing the power of the NHS” UKCRC's aim is to re-engineer the environment in which clinical research is conducted in the UK, to benefit the public and patients by improving national health and increasing national wealth. The UKCRC’s strength is that it brings together the major stakeholders that influence clinical research in the UK and particularly in the NHS. The UKCRC brings together the key organisations that shape the clinical research environment in the UK. This includes the main UK research funding bodies; academia; the NHS; regulatory bodies; the bioscience, healthcare and pharmaceutical industries; and patients… The UKCRC is also working to engage with patients and the public throughout its activities.

3c The UKCRN … Ensuring that patients and healthcare professionals from all parts of the country are able to participate in and benefit from clinical research 6 Topic Specific Research Networks & 29 Local Research Networks Putting pressure on the RNs to work with industry The role of the UKCRN is to develop a world-class infrastructure to ensure that high-quality research funded by both commercial and non-commercial orgs receives the support it needs to succeed… It offers a ‘rapid access, single point of access’ to the comprehensive healthcare research infrastructure within the UK. A dedicated ‘industry team’ to address the specific challenges and pressures faced by the healthcare industry in successfully delivering their research & d projects through the NHS. The industry team is ‘working closely with the healthcare industries, the DH and NHS Trusts in identifying barriers to the delivery of clinical research in the UK and formulating solutions and strategies to overcome these. Capacity to provide prompt and reliable assessment of study feasibility … Facilitation of study site activation thro the use of standardised agreements Rapid patient recruitment & delivery of high quality data for clinical studies across the full range of medical conditions Guided access for companies to the array of clinical & healthcare research expertise in the UK Accelerated product development…

3c The Mental Health Research Network (MHRN) “Providing the infrastructure to support large scale, high quality research in mental health and social care." 8 regional hubs Adoptions Committee SURGE (Service User Research Group England) Research interest groups To coordinate and facilitate the delivery of large-scale research projects that will inform policy and practice as it develops. To broaden the scope and capacity of research in mental health, including full involvement of service users and carers as well as frontline staff. To help identify the mental health research needs (particularly in health and social care) To develop research capacity through a range of initiatives at a local, regional and national level.

Patient & Public Involvement The new structure…? UKCRC ££ Work with Industry UKCRN This is my particular version of the new structure; my intention is to show the rather thin patient and public involvement lines of engagement compared to the pressures to work with industry. But, in any case, to clarify how each relates to each other. DRN DNDRN SRN NCRN MHRN MCRN Patient & Public Involvement

NHS patients for sale!? Large single funding body distant from patient and service user concerns Emphasis on (participation in) large scale clinical trials Funding follows the patient Networks are set up to encourage large scale trials Strong emphasis on working with industry (at the potential expense of user & carer involvement) A separate dedicated adoptions committee for industry trials Who is keeping an eye on ethics & good practice? Loss of service user research agenda - the emphasis on large scale trials is counter to the interests of most service users who wish to be involved in research as active participants. The methodology can be less conducive to real involvement, can be used to mystify and to dissuade people from involvement. However, the rational argument is hard to counter: certainly the conclusions we reach about the efficacy of drugs are bound to be more certain if based on larger trials. Involvement of service users may well serve to make these trials better, more relevant, more reality-based. The emphasis on working with industry, in the mental health field, is also counter to the interests of many service users who tend to see the pharmaceutical industry as making profits out of our distress. Trials have not, traditionally, taken into account serious concerns of service users taking these drugs in the real world – the unwanted effects of drugs, etc. They have often been poorly designed and not asked some key relevant questions. A separate adoptions committee aiming to fast-track drug company trials does not constitute a level playing field for other research, for example psychological treatments, as well as service user priorities. It is pandering to the drug companies, giving them the opportunity to market new drugs through the NHS. I am not sure who is keeping an eye on the ethics and good practice of this. Are there guidelines for adoptions committee on what sort of drug trials are ok, or are all assumed to be ok… are there guidelines for informed consent about the nature of these trials? Do the same ethical hoops have to be jumped through or not? Some of these are genuine questions, in that I do not know the answers. In our efforts to stay involved in this agenda and in these networks, are we in danger of losing touch with our own agenda and of losing touch with the grassroots of everyday experience that demands research that is meaningful, useful, applied to the lived experience of people at the receiving end of illnesses and services. Yes, there is ‘patient and public involvement’, and yes there is SURGE in the Mental Health RN… but how much more do we have to compromise to be involved? Our priorities do not contribute to the formation of research interest groups, our priorities are not high on this agenda at all.

4. The role of the (mental health) charities Historically important in supporting service user/survivor research – e.g. Mental Health Foundation, Sainsbury Centre for Mental Health; Loss of some strong initiatives (User Focused Monitoring, Strategies for Living); Funding shortages, pressures and biases affecting them too

5. We need user-led/survivor research! To: Stay in touch with and strengthen our agenda Stay in touch with the grassroots experience Ensure research is meaningful, relevant to people’s lived experience But: Who is doing it and where? Who is funding/ who will fund it? Politics vs. pragmatism Language of participation Capacity building Power and empowerment Why user-led research? To stay in touch with the grassroots experience To present and discuss alternative theoretical frameworks for what is going on To identify meaningful questions, meaningful outcomes To identify meaningful interventions To retain the whole person within the research, and not be fragmented into diagnoses and symptoms about which there is limited scientific agreement. It seems to me that we cannot count on this new strategy, this new structure and its motives and drivers to take us with it… How else are we to sustain the service user research agenda than to do our own research. The difficulty is that we need an infrastructure of our own, we need funding and we need capacity building. It is happening. I am fortunate in my work that I travel to many different places and find examples of service users and user groups doing their/our own research in all sorts of surprising places. The most recent being the forensic mental health services. But we still need more, we need to challenge the current language of participation, we still need more power and empowerment. I will leave you with a quotation from a survivor research and activist, Viv Lindow.

Arnstein’s ladder of participation Citizen control Delegated power Partnerships Placation or tokenism Consultation Information Community development Arnstein, 1971. A ladder of citizen participation. Journal of the American Institute of Planners 69, 216-224. Community engagement

Why research? “Research has its part to play in developing solidarity among psychiatric system survivors, and helping to raise the expectations of those who have been ‘educated’ to live with an unacceptable quality of life. Survival research can be a small but key part in the move to seize freedom within an oppressive and excluding society.” Viv Lindow, Survivor Researcher